Ruxotor Cream 30gm Tube
The Cost-Effective Generic Ruxolitinib 1.5% Solution
Offering the power of Ruxolitinib Phosphate INN in a high-quality, localized cream formulation. A reliable alternative to OPZELURA for patients, doctors, and institutions worldwide.
RUXOTOR Cream delivers the proven power of Ruxolitinib in an accessible, high-quality topical formulation. Manufactured by Everest Pharmaceuticals Limited, RUXOTOR offers a vital treatment option for various inflammatory and pigmentary skin conditions.
| Active Ingredient | Concentration | Formulation | Originator Reference |
| Ruxolitinib Phosphate INN | 1.5% (15 mg/gm) | Cream | OPZELURA (by INCYTE) |
Therapeutic Indications (Uses)
Mild to Moderate Atopic Dermatitis (Eczema)
- Indication: Short-term and non-continuous chronic treatment of mild to moderate eczema.
- Patient Criteria: Non-immunocompromised individuals 12 years of age and older whose disease is not adequately controlled with other topical prescription therapies or when those therapies are not recommended.
Nonsegmental Vitiligo
- Indication: Topical treatment of a type of vitiligo called nonsegmental vitiligo (a condition causing depigmentation of the skin).
- Patient Criteria: Adults and children 12 years of age and older.
Mechanism of Action
Ruxolitinib is a Janus Kinase (JAK) Inhibitor.
- Eczema and Vitiligo are linked to overactive immune responses in the skin.
- Ruxolitinib Cream works by weakening the skin’s local defense (immune) system, thereby decreasing the abnormal inflammatory (allergic) reaction and providing relief from symptoms like irritation and itching.
Dosage and Administration
| Instruction | Detail |
| Application | Apply a thin layer to the affected areas of skin. |
| Frequency | Usually applied twice daily. |
| Maximum Use | Do not use more than one 60 gram tube per week or one 100 gram tube per 2 weeks (Consult your local prescribing guidelines for exact limits). |
| Route of Use | For topical use only. |
| Restrictions | Not for ophthalmic (eyes), oral (mouth), or intravaginal use. |
Side Effect
The most common adverse reactions of Ruxolitinib Cream are:
Nasopharyngitis (common cold), diarrhea, bronchitis, ear infection, eosinophil count increased, urticaria, folliculitis, tonsillitis, rhinorrhea, increase in a type of white blood cell (eosinophil) count, folliculitis (hives inflamed hair pores), tonsillitis (swelling of the tonsils), headache, urinary tract infection, fever.
The above information comes from the Internet. Please consult with doctor for medical advice.
Ordering and Contact Information
Secure Your Supply of Ruxotor Cream Today
For order inquiries, bulk purchases, and export information, please contact Everest Pharmaceuticals Ltd. directly: Phone: +8801321220816
Email (Export/Sales): export@everestpharmabd.com
Disclaimer: Ruxotor Cream is a prescription medicine. Consult a qualified healthcare professional before use.